首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
外语
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolu
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolu
admin
2013-11-29
129
问题
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolution is based on the idea that the sicker people are, the more freedom they should have to try drugs that are not yet fully tested. For fifty years government policy has been driven by another idea: the fear that insufficiently tested medicines could cause deaths and injuries. The urgent needs of people infected with HIV, the AIDS virus, and the possibility of meeting them with new drugs have created a compelling countervailing force to the continuing concern with safety. As a result, government rules and practices have begun to change. Each step is controversial. But the shift has already gone far beyond AIDS. New ways are emerging for very sick people to try some experimental drugs before they are marketed. People with the most serious forms of heart disease, cancer, emphysema, Alzheimer’ s or Parkinson’ s disease, multiple sclerosis, epilepsy, diabetes, or other grave illnesses can request such drugs through their doctors and are likelier to get them than they would have been four years ago. "We’ve been too rigid in not making lifesaving drugs available to people who otherwise face certain death," says Representative Henry Waxman, of California, who heads the subcommittee that considers changes in drug-approval policies. "It’s true of AIDS, but it’s also true of cancer and other life- threatening diseases."
For the first time, desperate patients have become a potent political force for making new medicines available quickly. People with AIDS and their advocates, younger and angrier than most heart-disease or cancer patients, are drawing on two decades of gay activists’ success in organizing to get what they want from politicians. At times they found themselves allied with Reagan Administration deregulators, scientists, industry representatives, FDA staff members, and sympathetic members of Congress. They organized their own clinical trials and searched out promising drugs here and abroad. The result is a familiar Washington story: a crisis—AIDS—helped crystallize an informal coalition for reform.
AIDS gave new power to old complaints. As early as the 1970s the drug industry and some independent authorities worried that the Food and Do, g Administration’ s testing requirements were so demanding that new drugs were being unreasonably delayed. Beginning in 1972, several studies indicated that the United States had lost its lead in marketing new medicines and that breakthrough drugs—those that show new promise in treating serious or life-threatening diseases— had come to be available much sooner in other countries. Two high-level commissions urged the early release of breakthrough drugs. So did the Carter Administration, but the legislation it pro- posed died in Congress. Complaints were compounded by growing concern that "if we didn’t streamline policies, red tape wot, Id be an obstacle to the development of the biotechnology revolution," as Frank E. Young, who was the head of the FDA from 1984 to 1989, put it in an interview with me.
Young was a key figure in the overhaul of the FDA’s policies. A pioneer in biotechnology and a former dean of the University of Rochester’s medical school, he came to Washington with an agenda and headed the agency for five and a half years—longer than anyone else has since the 1960s. Young took the FDA job to help introduce new medicines created by biotechnology-- whose promise he had seen in his own gene-cloning lab--and to get experimental medicines to desperately iii people more quickly. He had seen people die waiting for new medicines because "they were in the wrong place at the wrong time," he said. That is now changing.
From the second paragraph, we learn that ______.
选项
A、AIDS people tend to get angrier than all cancer patients
B、AIDS people have learned some experience from homosexual people in dealing with politicians
C、AIDS people have got some representatives in government organizations
D、AIDS people often work together with gay activists
答案
B
解析
转载请注明原文地址:https://www.kaotiyun.com/show/vHhO777K
0
考博英语
相关试题推荐
ThedomesticeconomyintheUnitedStatesexpandedinaremarkablyvigorousandsteadyfashion.Therevivalinconsumerconfiden
Thelawofprivateinternationaltribunalswithrespecttoconflictsofinterestofarbitratorsisquiteextensive,albeitbyno
Thelawofprivateinternationaltribunalswithrespecttoconflictsofinterestofarbitratorsisquiteextensive,albeitbyno
Justiceinsocietymustincludebothafairtrialtotheaccusedandtheselectionofanappropriatepunishmentforthoseproven
Justiceinsocietymustincludebothafairtrialtotheaccusedandtheselectionofanappropriatepunishmentforthoseproven
Youheartherefrainallthetime:theU.S.economylooksgoodstatistically,butitdoesn’tfedgood.Whydoesn’tever-greater
Youshouldspendabout20minutesonthistask.Yourentahousethroughanagency.Theheatingsystemhasstoppedworking:
Inrecentyears,railroadshavebeencombiningwitheachother,mergingintosupersystems,causingheightenedconcernsaboutmo
Although"namingrights"haveproliferatedinAmericanhighereducationforthepastseveraldecades,thephenomenonhasrecentl
BetweentheinventionofagricultureandthecommercialrevolutionthatmarkedtheendoftheMiddleAges,wealthandtechnology
随机试题
下列不是学龄期儿童易患的疾病足
2017年1-4月,全国社会消费品网上零售额19180亿元,同比增长32.0%。其中,实物商品网上零售额14617亿元,增长25.9%;在实物商品网上零售额中,吃、穿和用类商品零售额分别增长19.3%、18.4%和29.5%。2017年4月,
长V形块在铣床夹具中定位轴类工件,可以克服工件___________自由度。
选择以下题中给出的四个结论中正确的一个结论:设在[0,1]上f’’(x)>0,则f’(0),f’(1),f(1)-f(0)或f(0)-f(1)几个数的大小顺序为().
《建设工程安全生产管理条例》的规定,工程监理单位和监理工程师应当按照法律、法规和()实施监理,并对建设工程安全生产承担监理责任。
一国的国内生产总值小于国民生产总值,说明该国公民从外国取得的收入大于外国公民从该国取得的收入。()
案例:王老师在进行“排球正面双手垫球”的课堂教学中,首先讲解了这项技术动作,然后简单介绍了技术动作的关键字“插”“夹”“提”“蹬”“伸”。学生向王老师询问这五个关键字的具体含义,他只是说你们自己体会,随后让学生进行练习。在练习过程中,王老师设计
有的人判断客观事物时容易受到外界因素的影响和干扰,这种认知方式属于()。
儿警察与行使职权无关的个人行为造成公民身体伤害的,国家一律不承担赔偿责任。()
Neartheendofafive-daytourofhighlyautomated,high-techJapanesefactories,theAmericanvisitorwasoverwhelmedandfeel
最新回复
(
0
)